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Abstract 
Neutrophils play an essential role in the innate immune response to microbial infection and are 
particularly important in clearing bacterial infection. We investigated the role of the transcription factor 
FOXO1 in the response of neutrophils to bacterial challenge with Porphyromonas gingivalis in vivo and in 
vitro. In these experiments, the effect of lineage-specific FOXO1 deletion in LyzM.Cre+FOXO1L/L mice was 
compared with matched littermate controls. FOXO1 deletion negatively affected several critical aspects 
of neutrophil function in vivo including mobilization of neutrophils from the bone marrow (BM) to the 
vasculature, recruitment of neutrophils to sites of bacterial inoculation, and clearance of bacteria. In vitro 
FOXO1 regulated neutrophil chemotaxis and bacterial killing. Moreover, bacteria-induced expression of 
CXCR2 and CD11b, which are essential for several aspects of neutrophil function, was dependent on 
FOXO1 in vivo and in vitro. Furthermore, FOXO1 directly interacted with the promoter regions of CXCR2 
and CD11b. Bacteria-induced nuclear localization of FOXO1 was dependent upon toll-like receptor (TLR) 2 
and/or TLR4 and was significantly reduced by inhibitors of reactive oxygen species (ROS and nitric oxide 
synthase) and deacetylases (Sirt1 and histone deacetylases). These studies show for the first time that 
FOXO1 activation by bacterial challenge is needed to mobilize neutrophils to transit from the BM to 
peripheral tissues in response to infection as well as for bacterial clearance in vivo. Moreover, FOXO1 
regulates neutrophil function that facilitates chemotaxis, phagocytosis, and bacterial killing. 
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Neutrophils play an essential role in the innate immune response to microbial infection 
and are particularly important in clearing bacterial infection. We investigated the role 
of the transcription factor FOXO1 in the response of neutrophils to bacterial challenge 
with Porphyromonas gingivalis in  vivo and in  vitro. In these experiments, the effect 
of lineage-specific FOXO1 deletion in LyzM.Cre+FOXO1L/L mice was compared with 
matched littermate controls. FOXO1 deletion negatively affected several critical aspects 
of neutrophil function in vivo including mobilization of neutrophils from the bone marrow 
(BM) to the vasculature, recruitment of neutrophils to sites of bacterial inoculation, and 
clearance of bacteria. In vitro FOXO1 regulated neutrophil chemotaxis and bacterial 
killing. Moreover, bacteria-induced expression of CXCR2 and CD11b, which are essen-
tial for several aspects of neutrophil function, was dependent on FOXO1 in vivo and 
in vitro. Furthermore, FOXO1 directly interacted with the promoter regions of CXCR2 
and CD11b. Bacteria-induced nuclear localization of FOXO1 was dependent upon toll-
like receptor (TLR) 2 and/or TLR4 and was significantly reduced by inhibitors of reactive 
oxygen species (ROS and nitric oxide synthase) and deacetylases (Sirt1 and histone 
deacetylases). These studies show for the first time that FOXO1 activation by bacterial 
challenge is needed to mobilize neutrophils to transit from the BM to peripheral tissues 
in response to infection as well as for bacterial clearance in  vivo. Moreover, FOXO1 
regulates neutrophil function that facilitates chemotaxis, phagocytosis, and bacterial 
killing.
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inTrODUcTiOn
Neutrophils are the first line of defense against invading pathogens (1). Bacteria induce neutro-
phil recruitment and mobilization. Neutrophils are recruited to sites of injury or infection early 
in the inflammatory process. After mobilization from the bone marrow (BM), neutrophils are 
rapidly recruited to the in infected peripheral tissues (2). This process is an important early step 
Abbreviations: ROS, reactive oxygen species; NOS, nitric oxide synthase; Sirt1, NAD-dependent deacetylase sirtuin-1; HDAC, 
histone deacetylases; TLR, toll-like receptor; CFSE, carboxyfluorescein succinimidyl ester; WGA, wheat germ agglutinin; MOI, 
multiplicity of infection; MFI, mean fluorescence intensity; Inh, inhibitor; PBL, peripheral blood; BM, bone marrow.
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in controlling tissue infections (2). In mice, the chemokines 
CXCL1/CXCL2 stimulate recruitment of neutrophils via CXCR2 
(3, 4). Neutrophils lacking CXCR2 are preferentially retained in 
the BM and have deficient recruitment of neutrophils following 
infection (5, 6). Thus, CXCL1-CXCR2-mediated neutrophil 
recruitment plays a critical role in protecting the host from 
bacterial infection (7–9).
Phagocytosis is a critical antimicrobial function of neutro-
phils that is needed to remove bacteria (10, 11). Complement 
factors C3b and C3bi opsonize bacteria, which in turn are 
phagocytized by neutrophils that carry the surface receptor 
CD11b/CD18 integrin, also known as complement receptor 
3 (12). After bacteria are phagocytosed, they are killed and 
lysed in lysosomes (13). Bacteria stimulate neutrophils through 
pattern recognition receptors including toll-like receptors 
(TLRs). TLR2 and TLR4 are membrane receptors that recognize 
pathogen-associated molecular patterns (14). After interacting 
with bacteria, TLR2 and TLR4 stimulate secretion of cytokines 
(15). TLR2/4 has been shown to induce a number of transcrip-
tion factors that induce antimicrobial activity in neutrophils. 
A transcription factor that has gained attention recently for its 
role in dendritic and lymphocyte function is FOXO1. We have 
recently shown that deletion of FOXO1 reduces dendritic cell 
function and impairs the ability of dendritic cells to activate the 
adaptive immune response (16). Previous results demonstrate 
that FOXO1 mediates LPS-induced cytokine expression in 
these cells (17). FOXO1 is needed for dendritic cell migration 
and homing to lymph nodes by regulating CCR7 and ICAM-1 
expression (16). FOXO1 promotes lymphocyte homeostasis 
by regulating CCR7 expression via binding to the promoter 
region of CCR7 in T cells (18, 19). FOXO1 induces monocyte/
macrophage activation and differentiation but does not affect 
CD11b expression (20).
Although it is well recognized that neutrophils are critical in 
the initial response to bacterial challenge and bacterial clearance, 
the mechanisms that control this response have not been fully 
explored. It is appreciated that TLRs play a key role in activation 
of neutrophils. However, the range of transcription factors that 
are triggered by bacteria-induced TLR signaling and their down-
stream gene targets have not been fully explored. The activation 
and function of the transcription factor FOXO1 in the neutrophil 
response to bacteria is unknown. To investigate the role of FOXO1 
in neutrophil function, we examined mice with lineage specific 
deletion of FOXO1. The results indicate that FOXO1 activity is 
stimulated in neutrophils, that FOXO1 regulates CD11b and 
CXCR2 and that FOXO1 mediates phagocytosis and bacterial 
killing, which are important for bacterial clearance. Furthermore, 
FOXO1 contributes to mobilizing neutrophil movement from a 
BM compartment to peripheral tissue.
MaTerials anD MeThODs
Mice
Mice that express Cre recombinase under control of the lysozyme 
M promoter (LyzM+.Cre) were purchased from The Jackson 
Laboratory (Bar Harbor, ME, USA). FOXO1L/L mice were generously 
provided by Dr. Ronald DePinho (University of Texas MD Anderson 
Cancer Center, Houston, TX, USA) (21). FOXO1L/L mice were 
bred with LyzM.Cre mice to generate experimental mice (LyzM.
Cre+FOXO1L/L) and the control littermates (LyzM.Cre−FOXO1L/L) 
as described (20). Genotypes were determined by PCR using prim-
ers specific for LyzM.Cre (5′-ATCCGAAAAGAAAACGTTGA-3′ 
and 5′-ATCCAGGTTACGGATATAGT-3′) and specific for FOXO1 
(5′-GCTTAGAGCAGAGATGTTCTCACATT-3′, 5′-CCAGA 
GTCTTTGTATCAG GCAAATAA-3′, and 5′-CAAGTCCATTA 
ATTCAGCACATTG A-3′). All procedures were approved by the 
Institutional Animal Care and Use Committee of the University of 
Pennsylvania.
Bacterial strains and animal injection
Broth-grown Porphyromonas gingivalis (ATCC, #33277) in loga-
rithmic growth phase was collected and washed three times with 
phosphate-buffered saline (PBS). Bacteria were then resuspended 
and counted with a standard CFU curve as previously described 
(22). Mice were challenged by injection of lightly fixed or live 
P. gingivalis (ATCC, #33277) or sham injection with vehicle 
alone (PBS) into the scalp connective tissue as described (23–25) 
and euthanized at indicated time points after the injection (26). 
Neutrophils were isolated from the vasculature, BM, and scalp 
connective tissues and assessed by flow cytometry after incubation 
with specific antibodies or control IgG as previously described 
(27). Neutrophil mobilization was calculated as described (28).
neutrophil isolation and cell culture
Primary mouse neutrophils were isolated from the BM (27). 
Briefly, BM cells from experimental mice (LyzM.Cre+FOXO1L/L) 
and the control littermates (LyzM.Cre−FOXO1L/L) were suspended 
in PBS without calcium and magnesium, placed over Histopaque® 
1119 and 1077 (Sigma Chemicals Ltd.) and centrifuged at 
2,000 rpm, 25°C for 30 min. The neutrophil layer was collected 
and washed twice in PBS. Neutrophil purity was routinely >95%, 
as determined by flow cytometry after staining for Ly6G, F4/80, 
and CD3 (27). Primary human neutrophils were isolated from 
human peripheral blood (PBL) of healthy donors obtained from 
the Human Immunology Core at University of Pennsylvania 
following the procedure in Ref. (27). Neutrophil purity (routinely 
>95%) was determined by Wright–Giemsa staining (27).
The human promyelocytic leukemia HL-60 cells (ATCC 
CCL-240) were cultured at 37°C in 5% CO2 in RPMI 1640 
supplemented with 2  mM l-glutamine, 25  mM HEPES, and 
10% heat-inactivated fetal bovine serum (MilliporeSigma, 
St. Louis, MO, USA). HL-60 cells were incubated with 1.3% DMSO 
(MilliporeSigma) for 4  days (29) and their differentiation into 
neutrophils (referred to as HL-60 neutrophils) was monitored by 
flow cytometry analysis by CD11b expression using antihuman 
CD11b mAb (BD Pharmingen) (27).
neutrophil Migration
Chemotaxis was measured in primary mouse BM neutrophils 
with transwell chambers (polycarbonate filter, 5-µm pore size, 
Corning) with or without CXCL1 (Peprotech) for 2 h at 37°C in 
the bottom chamber. Neutrophils that migrated to the bottom 
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side of the filter were counted by DAPI staining and fluorescence 
microscopy.
neutrophil Phagocytosis, clearance and 
Bacterial Killing
Bacterial phagocytosis was performed as described (30) with modi-
fication. Briefly, bacteria were labeled with CFSE (#65-0850-84, 
carboxyfluorescein succinimidyl ester, Thermo Fisher Scientific, 
Waltham, MA, USA) (31) and incubated with neutrophils at 
multiplicity of infection (MOI) 1:10 (cell: bacteria) for 1 h. The 
neutrophils were fixed and stained with Alexa 647-labeled wheat 
germ agglutinin (WGA) (W32466, Thermo Fisher Scientific) to 
delineate the cell surface (red) and internalized bacteria (green) 
then visualized by fluorescent microscopy with deconvolution. 
Internalized bacteria were considered as those within WGA-
decorated plasma membranes (27). Neutrophil-associated bac-
teria were determined by colocalizing CFSE-labeled P. gingivalis 
and Alexa 647-labeled WGA stained neutrophils. Internalized 
bacteria and neutrophils with associated bacteria were counted 
under fluorescent microcopy (27). Bacterial clearance in  vivo 
was determined by inoculating P. gingivalis (1 ×  107 bacteria/
injection) into the scalp connective tissue of experimental LyzM.
Cre+FOXO1L/L and LyzM.Cre−FOXO1L/L control littermates, 
a well-characterized experimental model (23–26). The scalp soft 
tissue was harvested, mechanically processed by medimachine 
(BD Biosciences, San Jose, CA, USA), lysed, and divided into 
aliquots with multiple dilutions that were used for numeration 
of recovered CFU (colonies were counted after anaerobic culture 
on blood agar plates). Data are presented as total number of 
bacteria recovered per mouse (27). To assess bacterial killing 
in  vitro mouse neutrophils were cocultured with P. gingivalis 
(MOI =  1:1) (cell: bacteria) at 37°C and 5% CO2 for 2  h. The 
neutrophils were lysed and viable CFU were enumerated after 
anaerobic culture on blood agar plates. The neutrophil killing 
index was calculated according to the formula: [(CFU in the 
absence of neutrophils − CFU in the presence of neutrophils)/
CFU in the absence of neutrophils] × 100 (27).
Treatment by inhibitors
The inhibitors for reactive oxygen species (ROS, NAC, N-acetyl-
l-cysteine, 5  mM) (32), nitric oxide synthase (NOS, l-NAME, 
NG-nitro-l-arginine methyl ester, 5  mM) (33), Sirt1 (Sirtinol, 
10  µM), histone deacetylases (HDAC, Trichostatin A, TSA, 
2  µM), TLR4 (TAK242, 1  µg/mL), and DMSO were obtained 
from MilliporeSigma (Billerica, MA, USA) or Cayman Chemical 
(Ann Arbor, MI, USA). TLR2 blocking antibody (10 μg/mL) and 
matched mouse IgG2a (10  µg/mL) were obtained from Santa 
Cruz Biotechnology (Dallas, TX, USA). HL-60 neutrophils were 
incubated with inhibitors or antibody compared to vehicle or 
matched control IgG for 1  h before P. gingivalis challenge and 
during incubation with bacteria. After 16 h, cells were fixed and 
examined by immunofluorescence with antibody to FOXO1 
compared to matched control IgG. FOXO1 nuclear localization 
was assessed by FOXO1 colocalization with DAPI nuclear stain 
by image analysis with NIS-Elements software (Nikon, Melville, 
NY, USA).
immunofluorescence analysis
HL-60 neutrophils were incubated with P. gingivalis in 96-well 
plates for 12 h at 37°C. Neutrophils were fixed in 3.7% formal-
dehyde for 10  min, permeabilized in 0.5% Triton X-100 for 
5 min, blocked in 2% BSA, and stained with primary antibody 
and appropriate isotype-matched negative control antibody. This 
was followed by incubation with biotinylated secondary antibody 
and ABC reagent and visualized by incubation with Alexa Fluor 
546-conjugated streptavidin (#S11225, Thermo Fisher Scientific) 
with DAPI counterstain (#62248, Thermo Fisher Scientific). 
Images were captured at a magnification of 200× with a fluo-
rescence microscope (Nikon) with the same exposure time for 
experimental and negative control groups. The capture time was 
set so that control antibody images were negative. Image analysis 
was performed using NIS Elements AR image analysis software. 
The percentage of immunofluorescence positive cells or mean 
fluorescence intensity (MFI) was measured.
Transient Transfection and Quantitative 
real-time Pcr
Neutrophils were transfected with a plasmid containing consti-
tutively active FOXO1, FOXO1-AAA (referred to as FOXO1), 
or pcDNA empty vector as we have described (34) by electropo-
ration with Amaxa Nucleofector Transfection Device (Lonza, 
Basel, Switzerland) or Neon Transfection System (Thermo Fisher 
Scientific) following the manufacturer’s instructions. Cells were 
then stimulated with P. gingivalis as MOI 1:10 overnight. Total 
RNA was extracted from neutrophils and gene expression was 
then measured by quantitative real-time PCR with primers (IDT, 
Coralville, IA, USA) designed using the Universal Probe Library 
Assay Design Center (Roche Applied Science, Indianapolis, IN, 
USA) and labeled probes (Roche Applied Science). Each value 
was normalized to ribosomal protein L32 and represents the 
mean of three independent experiments.
Human primary neutrophils were transfected with FOXO1 
siRNA as described (27). Briefly, ON-TARGET plus SMART 
pool siRNAs specific for FOXO1 and control scrambled 
non-targeting control pool siRNA were obtained from GE 
Healthcare Lifesciences (Pittsburgh, PA, USA) and transfection 
was performed using lipofectamine 3000 Transfection Reagent 
(L3000008, Thermo Fisher Scientific) according to the manufac-
turer’s instructions.
Western Blot
Neutrophils were lysed with lysis buffer (sc-24948, Santa Cruz 
Biotechnology) containing protease inhibitor cocktail and phos-
phatase inhibitor cocktail. Protein concentration was measured 
using a protein assay with BSA as a standard (#26149, Thermo 
Fisher Scientific). The 30–60 µg cell lysate was resolved in 4–20% 
SDS-PAGE (#4561084, Bio-Rad Laboratories) and transferred 
onto PVDF membrane (#88518, Thermo Fisher Scientific). The 
membranes were incubated with primary antibodies against 
FOXO1 (#2880S, 1:500, rabbit mAb, Cell Signaling Technology) 
and β-actin (A5316, 1:1,000, MilliporeSigma) after blocking with 
5% milk. The samples were then incubated with horseradish 
peroxidase-labeled donkey antirabbit IgG (NA934, 1:5,000, GE 
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Healthcare) or antimouse IgG (HAF018, 1:5,000, R&D), and 
immunoreactive bands were detected with ECL Western blotting 
reagents (#32209, Thermo Fisher Scientific).
chromatin immunoprecipitation (chiP) 
assays
Chromatin immunoprecipitation assays were performed using a 
ChIP-IT Kit (#53035, Active Motif, Carlsbad, CA, USA). Cells 
were fixed in 1% formaldehyde, DNA sheared enzymatically 
and immunoprecipitated with anti-FOXO1 or matched control 
antibody and captured with magnetic protein G beads. The 
precipitated DNA was then amplified by real-time SYBR green 
real-time PCR using primers for CD11b and CXCR2.
apoptosis In Vitro
Apoptosis were measured by flow cytometry with Annexin 
V FITC apoptosis detection kit (#88-8005, Thermo Fisher 
Scientific) according to the manufacturer’s instructions. In brief, 
neutrophils were coculture with P. gingivalis for overnight and 
assessed by flow cytometry after stained with Annexin V. Data 
were analyzed by Flow Jo software.
statistical analysis
Experiments were carried out a minimum of two to three times 
with similar results. Statistical significance was determined by 
t-test or ANOVA with Turkey’s post hoc test at P < 0.05.
resUlTs
FOXO1 Deletion impairs Bacteria-induced 
neutrophil Mobilization In Vivo
To examine host bacteria interactions in  vivo, we utilized a 
well-defined animal model in which bacteria are inoculated 
into the scalp connective tissue (23–25). The number of mature 
neutrophils, T  cells, B  cells, and macrophages recruited to the 
site of inoculation following injection of bacteria was measured 
by immunofluorescent flow cytometry using specific antibodies 
or matched control antibody. As expected, the major leukocyte 
recruited were neutrophils, which were far greater than T cells, 
B cells, and macrophages (P < 0.05) (Figure 1A). To determine 
whether FOXO1 plays a role in bacteria-induced neutrophil 
recruitment, experimental mice were examined in which floxed 
FOXO1 was deleted in myeloid cells by Cre recombinase under 
the control of a LyzM promoter element (LyzM.Cre+FOXO1L/L) 
and compared with littermate controls (Figures  1B–F). The 
expression of CD11c.Cre+ recombinase has no apparent affect 
as demonstrated by comparison with wild-type mice as reported 
(35). Bacterial inoculation stimulated a 16-fold increase in the 
number of neutrophils recruited in WT control mice at 24  h, 
which was reduced 80% in LyzM.Cre+FOXO1L/L experimental 
mice (P < 0.05) (Figure 1C). The number of mature neutrophils 
in the blood (Figures 1B,D) and BM (Figure 1E) was measured 
by immunofluorescent flow cytometry to examine the role of 
FOXO1 in neutrophil redistribution following inoculation of 
bacteria. After 12 h, there was a 4.6-fold increase in neutrophil 
numbers in the PBL of control mice, which was 68% lower in 
experimental LyzM.Cre+FOXO1L/L mice (P < 0.05) (Figure 1D). 
This coincided with a 52% decrease in the number of neutrophils 
in the BM of control mice 12 h following bacterial inoculation. 
Thus, deletion of FOXO1 in LyzM.Cre+FOXO1L/L experimental 
mice caused a significant reduction in the movement of neutro-
phils from the BM to PBL after bacterial inoculation (P < 0.05) 
(Figure 1E). Quantitatively, bacteria induced a fivefold increase 
in neutrophil mobilization from the BM compartment to the 
peripheral vasculature in WT control mice at 12 h, which was 
reduced by more than 50% in FOXO1-deleted experimental mice 
in vivo (Figure 1F). To ensure that FOXO1 was deleted, neutro-
phils from LyzM.Cre+FOXO1L/L and matched control mice were 
examined (P <  0.05) (Figures  1G,H). At both the mRNA and 
protein level, the results demonstrate efficient FOXO1 deletion in 
neutrophils in the experimental but not control groups.
FOXO1 Deletion interferes with neutrophil 
chemotaxis
To determine whether FOXO1 facilitates neutrophil migration, 
in  vitro studies were carried out. Neutrophils were stimulated 
with the chemokine CXCL1 and examined in a transwell assay. 
CXCL1 induced a dose-dependent increase in migration that was 
stimulated up to sevenfold in control mice and reduced by 45% 
when FOXO1 was deleted (P < 0.05) (Figure 2A). To examine 
how FOXO1 may affect neutrophil migration, CXCR2, a receptor 
for CXCL1, was assessed. Bacteria induced a 2.3-fold increase in 
CXCR2 mRNA levels (P < 0.05) that was 44% lower in similarly 
stimulated neutrophils from experimental littermates (P < 0.05) 
(Figure 2B). Regulation of CXCR2 by FOXO1 was further exam-
ined by transfection of HL-60 neutrophils with a FOXO1 expres-
sion plasmid. FOXO1 plasmid increased CXCR2 mRNA levels 
2.2-fold and protein levels by 1.6-fold compared to empty vector 
(Figures 2C,D). Moreover, the increase was further enhanced in 
cells stimulated with bacteria, suggesting that FOXO1 enhances 
CXCR2 in cooperation with other factors that are induced in 
neutrophils stimulated with bacteria. Direct interaction between 
FOXO1 and the CXCR2 promoter was demonstrated by ChIP 
assay, which was also significantly enhanced in bacteria stimu-
lated neutrophils (P < 0.05) (Figure 2E). Furthermore, FOXO1 
protein levels were increased in neutrophils transfected with a 
FOXO1 expression plasmid (P < 0.05) (Figure 2F). Thus, FOXO1 
mediates CXCR2 transcription stimulated by bacteria and dele-
tion of FOXO1 in neutrophils reduces chemotaxis induced by its 
cognate ligand.
FOXO1 Deletion impairs neutrophil 
Phagocytosis and Bacterial Killing
The impact of FOXO1 deletion on neutrophil phagocytosis was 
examined. Phagocytosis was assessed by internalization of labeled 
bacteria. Neutrophils phagocytosis of bacteria was reduced ~60% 
(Figures 3A–C) (P < 0.05) when FOXO1 was knocked down. The 
number of neutrophils with associated bacteria was reduced in half 
(P < 0.05) (Figure 3D). Since a primary function of neutrophils 
is bacterial killing, we assessed this parameter in vivo 12 h after 
injection of bacteria and in vitro 2 h after coincubation, time points 
at which neutrophils are the primary antibacterial defense (36). 
FigUre 1 | FOXO1 deletion impairs bacteria-induced neutrophil recruitment. (a,B) Porphyromonas gingivalis was inoculated into the connective tissue of the scalp 
and mice were examined at the indicated time points. (a) The mice was euthanized at 12 h and number of cells in the inoculated tissue and (B) neutrophils in 
peripheral blood were measured by immunofluorescent flow cytometry using specific antibodies for neutrophils (Ly6G), T cells (CD3), B cells (B220), and 
macrophages (F4/80). FOXO1-deleted LyzM.Cre+FOXO1L/L mice and littermate control LyzM.Cre−FOXO1L/L mice were inoculated with bacteria at the indicated time 
points. The number of neutrophils in the inoculated tissue (c), peripheral blood (D), and bone marrow (e) was measured by immunofluorescent flow cytometry 
using specific antibodies. (F) Neutrophil mobilization was calculated as described in methods to estimate the percentage of total neutrophils in the blood. RNA was 
isolated from mouse neutrophils from FOXO1-deleted LyzM.Cre+FOXO1L/L mice and littermate control LyzM.Cre−FOXO1L/L mice. FOXO1 mRNA levels were 
measured by RT-PCR and normalized to ribosomal protein L32 (g). (h) Neutrophils from experimental LyzM.Cre+FOXO1L/L mice and littermate control LyzM.
Cre−FOXO1L/L mice were analyzed by Western blots for FOXO1 expression with actin as loading control. The data are representative of two or three independent 
experiments. Data are presented as the mean ± SEM from triplicate samples. *Significant difference between neutrophils from FOXO1-deleted LyzM.Cre+FOXO1L/L 
mice and littermate control LyzM.Cre−FOXO1L/L mice (P < 0.05).
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FigUre 2 | FOXO1 is needed for neutrophil migration and CXCR2 expression. (a) Migration was examined in neutrophils from FOXO1-deleted LyzM.Cre+FOXO1L/L 
mice or littermate control LyzM.Cre−FOXO1L/L mice in transwell chambers. CXCL1 was added to the bottom chamber and neutrophils that migrated to the bottom 
chamber were quantified following DAPI staining and fluorescence microscopy. (B) Bacteria were incubated with neutrophils from FOXO1-deleted LyzM.
Cre+FOXO1L/L and control LyzM.Cre−FOXO1L/L mice. CXCR2 mRNA levels were measured by RT-PCR and normalized to ribosomal protein L32. (c) HL-60 
neutrophils were transfected with FOXO1 or empty vector alone and stimulated with bacteria or vehicle alone. RNA was isolated from neutrophils. CXCR2 
expression was measured by real-time PCR. (D) CXCR2 protein levels were assessed by mean fluorescence intensity (MFI). (e) Chromatin immunoprecipitation 
(ChIP) assays were performed with neutrophils from control LyzM.Cre−FOXO1L/L mice. (F) HL-60 neutrophils were transfected with FOXO1 expression plasmid or 
empty vector alone and FOXO1 protein levels were measured by immunoblot with a specific antibody. Actin was assessed as a loading control. The data are 
representative of two or three independent experiments. Data are expressed as the mean ± SEM from triplicate samples. *Significant difference between neutrophils 
from FOXO1-deleted LyzM.Cre+FOXO1L/L mice and littermate control LyzM.Cre−FOXO1L/L mice (P < 0.05). *Significant difference between HL-60 neutrophils from 
transfection of FOXO1 vs. empty vector alone (P < 0.05).
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FigUre 3 | FOXO1 deletion impairs neutrophil bacterial phagocytosis. (a) Carboxyfluorescein succinimidyl ester (CFSE)-labeled bacteria were incubated with 
human HL-60 neutrophils transfected with scrambled or FOXO1siRNA. Deconvolution fluorescent microscopic images were taken after the neutrophils were stained 
with Alexa 647-labeled wheat germ agglutinin (WGA) to delineate the cell surface (red) and internalized bacteria (green). Internalized bacteria were considered as 
those within WGA-labeled plasma membranes. (B) Internalized bacteria expressed as the number of bacteria internalized per cell. (c) The percent neutrophils with 
phagocytosed bacteria. (D) The percent neutrophils with associated bacteria. (e) FOXO1-deleted LyzM.Cre+FOXO1L/L and control LyzM.Cre−FOXO1L/L mice were 
inoculated with Porphyromonas gingivalis in vivo. Live bacterial CFUs were measured. (F) Neutrophils from FOXO1-deleted LyzM.Cre+FOXO1L/L mice and littermate 
control LyzM.Cre−FOXO1L/L mice were isolated and incubated with P. gingivalis in vitro. Viable bacterial CFUs were counted. (g) RNA was isolated from neutrophils 
and FOXO1 was measured by real-time PCR. (h) Neutrophils transfected with the siRNA were analyzed by Western blots using a antibody specific for FOXO1. Actin 
was assessed as a loading control. The data are representative of two or three independent experiments of mean ± SEM from triplicate samples. *Significant 
difference between human neutrophils from transfection of FOXO1 siRNA vs. scramble siRNA (P < 0.05). *Significant difference between neutrophils from 
FOXO1-deleted LyzM.Cre+FOXO1L/L mice and littermate control LyzM.Cre−FOXO1L/L mice (P < 0.05). SCR, scrambled siRNA; UT, untransfected control.
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In vivo, FOXO1 deficient mice were 70% less efficient in clear-
ing bacteria than matched littermate control mice (P <  0.05) 
(Figure 3E). Similar results were obtained in vitro. Neutrophils 
from experimental mice with lineage specific FOXO1 deletion 
were 50% less efficient than control littermates in bacterial killing 
(P < 0.05) (Figure 3F). Experiments were carried out to ensure 
that FOXO1 was efficiently knocked down by RNAi. At both 
the mRNA (Figure 3G) and protein levels (Figure 3H), FOXO1 
siRNA substantially reduced FOXO1 compared to scramble 
siRNA.
FigUre 4 | Bacteria stimulate FOXO1 nuclear localization through TLR signaling. (a) HL-60 neutrophils were incubated with TLR2 blocking antibody or matched 
control IgG or TLR4 inhibitor (TAK242) individually or combined. Cells were alternatively incubated with inhibitors to reactive oxygen species (ROS, NAC), NOS 
(L-NAME), Sirt1(Sirtinol), histone deacetylases (HDAC, Trichostatin A, TSA), or control vehicle alone, DMSO. (a) FOXO1 nuclear localization was determined by 
immunofluorescence using an antibody specific to FOXO1 and colocalization with DAPI nuclear stain. (B) Quantitation was determined by percent neutrophils with 
FOXO1 nuclear translocation. The data are representative of two or three independent experiments and expressed as the mean ± SEM from triplicate samples. 
*Significant difference between neutrophils incubated with bacteria or phosphate-buffered saline (P < 0.05) or #treated with inhibitor and vehicle or isotype IgG 
control (P < 0.05).
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Bacteria induce FOXO1 nuclear 
localization
Experiments were undertaken to better understand mecha-
nisms through which bacteria stimulate FOXO1 nuclear 
localization, a key step in induction of FOXO1 activity. Bacteria 
stimulated FOXO1 nuclear localization by approximately 
fourfold. Bacteria-stimulated FOXO1 nuclear localization 
was dependent upon TLRs since inhibitors of TLR2 and TLR4 
blocked most of this increase (P  <  0.05) (Figures  4A,B). 
Inhibition of ROS and NOS, intermediates in TLR signaling 
also substantially reduced bacteria-induced FOXO1 nuclear 
localization. Furthermore, deacetylation of FOXO1 played an 
important role as inhibitors that blocked FOXO1 deacetyla-
tion, Sirt1 and HDAC largely blocked the ability of bacteria 
to stimulate translocation of FOXO1 to the nucleus (P < 0.05) 
(Figures 4A,B).
FigUre 5 | FOXO1 regulates CD11b expression. (a) Neutrophils were isolated from FOXO1-deleted LyzM.Cre+FOXO1L/L and control LyzM.Cre−FOXO1L/L mice and 
incubated with Porphyromonas gingivalis. (a) RNA was isolated from neutrophils and CD11b mRNA levels were measured by RT-PCR and normalized to ribosomal 
protein L32. (B) HL-60 neutrophils were transfected with a plasmid expressing FOXO1 or empty vector alone with or without incubation with bacteria. RNA was 
isolated from neutrophils and CD11b measured by real-time PCR. (c) HL-60 neutrophils were transfected with FOXO1 expression plasmic or vector alone. 
Immunofluorescence was carried out using a CD11b specific antibody and DAPI counterstain. Intensity was measured to assess protein levels of CD11b. (D) Cells 
described in panel C were assessed for mean fluorescence intensity (MFI) to quantify CD11b protein levels. (e) FOXO1 interaction with the CD11b promoter examined 
by chromatin immunoprecipitation (ChIP) assay using primary murine neutrophils from normal mice. The data are representative of two or three independent 
experiments and expressed as the mean ± SEM from triplicate samples. *Significant difference between neutrophils from FOXO1-deleted LyzM.Cre+FOXO1L/L mice 
and littermate control LyzM.Cre−FOXO1L/L mice (P < 0.05). *Significant difference between neutrophils from transfection of FOXO1 vs. empty vector alone (P < 0.05).
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FOXO1 regulates cD11b expression
To investigate a potential mechanism by which FOXO1 affects 
several aspects of neutrophil function including migration and 
phagocytosis (37), we examined FOXO1 regulation of CD11b. 
Under basal conditions neutrophils from mice with FOXO1 
deletion had 50% less CD11b mRNA than control littermates 
(P < 0.05) (Figure 5A). Bacterial stimulation increased neutrophil 
CD11b mRNA levels almost fivefold in vitro (P < 0.05). More than 
50% of this increase was blocked in neutrophils from experimental 
FOXO1-deleted mice (P < 0.05) (Figure 5A). To further investigate 
regulation of CD11b, HL-60 neutrophils were transfected with 
FOXO1 or empty vector alone and stimulated with bacteria. 
Overexpression of FOXO1 induced a significant 3.9-fold increase 
in CD11b mRNA levels and 1.6-fold increase at the protein level 
compared to empty vector (Figures 5B–D). To determine whether 
FOXO1 regulates neutrophil activity directly, interaction between 
FOXO1 and the CD11b promoter was examined by ChIP assay. 
Under basal conditions FOXO1 was shown to interact directly 
with the CD11b promoter, which was increased almost threefold 
in neutrophils stimulated by bacteria (P < 0.05) (Figure 5E).
FigUre 6 | FOXO1 regulates TLR expression in neutrophils. (a,B) Bacteria were incubated with neutrophils from FOXO1-deleted LyzM.Cre+FOXO1L/L and littermate 
control LyzM.Cre−FOXO1L/L mice. RNA was isolated and mRNA levels of TLR2 and TLR4 were measured by RT-PCR and normalized to ribosomal protein L32. 
(c–F) HL-60 neutrophils were transfected with FOXO1 or empty vector alone and stimulated with bacteria or vehicle alone. RNA was isolated and real-time PCR 
was carried out to assess mRNA levels of TLR2 and TLR4 or immunofluorescence was carried out with antibody specific for TLR2 or TLR4 and protein levels were 
assessed by mean fluorescence intensity (MFI). (g) Neutrophils were isolated from bone marrow of FOXO1-deleted LyzM.Cre+FOXO1L/L mice and littermate control 
LyzM.Cre−FOXO1L/L mice by break free centrifugation on Histopaque 1119 and 1077 and washed by phosphate-buffered saline (PBS) without calcium/magnesium. 
Alternatively HL-60 neutrophils were transfected with scrambled siRNA (SCR) or FOXO1 siRNA or were transfected with FOXO1 expression plasmid (FOXO1) or 
empty vector alone (pcDNA). Cells were incubated with P. gingivalis (Bact) (multiplicity of infection 1:10) for 12 h or vehicle alone (VEH) at 37°C with 5% CO2 at 
normoxic moisture conditions. Apoptotic cells were assessed by flow cytometry with Annexin V labeling. The positive control was HL-60 neutrophils incubated with 
camptothecin. The data are representative of two or three independent experiments and expressed as the mean ± SEM from triplicate samples. *Significant 
difference between neutrophils from FOXO1-deleted LyzM.Cre+FOXO1L/L mice and littermate control LyzM.Cre−FOXO1L/L mice (P < 0.05). *Significant difference 
between HL-60 neutrophils from transfection of FOXO1 vs. empty vector alone or human neutrophils scrambled or FOXO1siRNA transfected (P < 0.05).
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FOXO1 regulates Bacteria-induced Tlr 
and cytokines expression
Bacterial stimulation increased TLR2 and TLR4 mRNA levels 
twofold to threefold and most of this increase was blocked in neu-
trophils with deleted FOXO1 (P < 0.05) (Figures 6A,B). Similarly, 
overexpression of FOXO1 increased TLR2 and TLR4 mRNA and 
protein levels particularly in neutrophils coincubated with bacteria 
(Figures  6C–F). Thus, FOXO1 can potentially sensitize neutro-
phils to bacterial stimulation through upregulation of TLRs to 
enhance inflammatory responses. To determine whether changes 
FigUre 7 | FOXO1 regulates TNFα and IL-1β. (a,B) Neutrophils from FOXO1-deleted LyzM.Cre+FOXO1L/L mice and littermate control LyzM.Cre−FOXO1L/L mice 
were incubated with Porphyromonas gingivalis. RNA was isolated from neutrophils and mRNA levels of TNFα or IL-1β were measured by RT-PCR and normalized to 
ribosomal protein L32. (c–F) HL-60 neutrophils were transfected with FOXO1 or empty vector alone and stimulated with bacteria or vehicle. (c,D) RNA was isolated 
from neutrophils and mRNA levels of TNFα and IL-1β measured by real-time PCR. (e,F) Cells were incubated with anti-TNFα or anti-IL-1β antibody (sc-7884, Rabbit 
Polyclonal IgG 1:50, Santa Cruz Biotechnology, Santa Cruz, CA, USA) overnight and then with secondary antibody, donkey antirabbit biotinylated antibody (1:200, 
Jackson ImmunoResearch Laboratories, West Grove, PA) for 1 h at room temperature in a box with the humidified atmosphere, followed by incubation with 
streptoavidin-Alexa 546 (S-11225, 1:400, for 1 h, Thermo Fisher Scientific). The mean fluorescence intensity (MFI) was measured to assess protein levels of each. 
The data are representative of two or three independent experiments and expressed as the mean ± SEM from triplicate samples. *Significant difference between 
neutrophils from FOXO1-deleted LyzM.Cre+FOXO1L/L mice and littermate control LyzM.Cre−FOXO1L/L mice (P < 0.05). *Significant difference between HL-60 
neutrophils transfected with FOXO1 expression plasmid vs. empty vector alone for mRNA or protein level (P < 0.05).
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in neutrophils modulated by FOXO1 could be due to apoptosis, 
experiments were carried out assessing apoptosis by Annexin V. 
Bacteria stimulated a small increase in neutrophil apoptosis that 
was much less than the positive control, camptothecin (Figure 6G). 
However, deletion of FOXO1 by Cre recombinase or knockdown of 
FOXO1 by siRNA had no effect on neutrophil apoptosis.
FOXO1 may contribute to inflammatory responses of neu-
trophils by upregulating cytokine expression. FOXO1 deletion 
in neutrophils reduced the capacity of bacteria to induce TNFα 
and IL-1β mRNA levels by 50–70% (P < 0.05) (Figures 7A,B). 
Although IL-1β mRNA levels are not directly related to mature 
IL-1β protein levels, the results do show FOXO1 regulation 
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IL-1β mRNA. The effect of transfection of a FOXO1 expression 
plasmid on TNFα and IL-1β was also assessed. Transfection with 
FOXO1 stimulated approximately fivefold increase in TNFα and 
IL-1β mRNA (Figures 7C,D). When neutrophils were stimulated 
with bacteria plus FOXO1 overexpression the levels were further 
increased to 25-fold for TNFα and >100-fold for IL-1β. A similar 
synergy between FOXO1 overexpression and bacterial stimula-
tion was observed when the protein levels were measured by MFI 
(Figures 7E,F).
DiscUssiOn
FOXO1 is a transcription factor present in many cell types. Previous 
studies demonstrated that FOXO1 regulates cytokine production 
in dendritic cells and macrophages (38), dendritic cell homing to 
lymph nodes and lymphocyte activation (16, 18, 39) Lymphocyte 
trafficking to secondary lymphoid organs (40) and formation of 
germinal centers (18, 41–43) is also FOXO1 dependent. We show 
here for the first time that FOXO1 is needed to mobilize neutro-
phils from the BM to the vasculature and to recruit neutrophil to 
sites of bacterial inoculation. Moreover, FOXO1 plays a critical 
role in upregulating antibacterial neutrophil responses that clear 
bacterial infection including phagocytosis and bacterial killing.
Mobilization of neutrophils from the BM to the vasculature is 
an early and important step in the response to bacterial infection 
(44). The BM is the site of neutrophil production where neu-
trophils mature and are released into the circulation. Infection 
causes a relocation of neutrophils by mobilizing their release 
from BM followed by an increase in circulating neutrophils and 
recruitment to the infected site (44). FOXO1 deletion in neutro-
phils significantly reduced neutrophil mobilization from the BM. 
This was reflected in both an increase in the number of neutro-
phils that were present in the BM of experimental mice and the 
reduced numbers that were circulating following inoculation of 
bacteria. CXCR2 is critical for neutrophil mobilization as neutro-
phils lacking CXCR2 are retained in the BM and have a reduced 
mobilization from BM to vasculature (5). The role of CXCR2 
is based on the findings that recruitment of neutrophils to the 
lungs following Streptococcus pneumoniae infection is reduced 
by CXCR2 ablation (45). Since CXCR2 is the primary chemokine 
receptor that regulates neutrophil mobilization, we determined 
whether it was regulated by FOXO1. FOXO1 interacted directly 
with the CXCR2 promoter, FOXO1 deletion reduced bacteria-
induced CXCR2 in vitro and in vivo and FOXO1 overexpression 
increased its mRNA levels. These results strongly support the 
capacity of FOXO1 to regulate expression of CXCR2 and thereby 
modulate neutrophil mobilization. However, it does not rule out 
the possibility that FOXO1 deletion in macrophages also affects 
neutrophil recruitment in the experimental mice. It is noteworthy 
that the number of neutrophils in the BM did not change with 
FOXO1 deletion under steady-state conditions indicating that the 
changes that we observed were due to mobilization of neutrophils 
rather than their production or maturation.
We found that deletion of FOXO1 significantly reduced the 
clearance of inoculated bacteria. This was shown by a fourfold 
reduction in bacteria present in matched control mice compared 
to mice with FOXO1 deletion. Most of this reduction occurred 
within a 16  h time frame in which the majority of bacteria 
removed by the innate immune response is due to the activity of 
neutrophils (36). Within the time frame of the study by far the 
predominant leukocyte was neutrophils, with small amounts of 
T cells followed by macrophages and B cells, consistent with other 
studies that neutrophils are predominantly responsible for early 
clearance of bacteria following infection (27). Ablation of FOXO1 
in neutrophils significantly reduced their capacity to phagocyt-
ize bacteria and kill bacteria in vitro. The former is likely due to 
FOXO1 regulation of CD11b, which interacts with CD18 to play 
an important role in capture of bacteria (46). CD11b promotes 
phagocytosis of bacteria (47). FOXO1 ablation also reduced the 
number of neutrophils recruited to the site of bacterial inoculation. 
The reduced numbers of neutrophils may also negatively impact 
the ability to clear bacteria in  vivo. In addition to P. gingivalis, 
we have also examined FOXO1 dependent neutrophil responses to 
a Gram-positive bacterium, Bacillus subtilis. B. subtilis stimulated 
FOXO1 nuclear localization; neutrophil phagocytosis and killing 
of B. subtilis in vitro was FOXO1 dependent (data not shown).
Bacteria induce FOXO1 activation through TLR2/4 as shown 
by significantly reduced FOXO1 nuclear localization with 
TLR2/4 inhibitors. This is likely to be mediated by ROS/NOS and 
deacetylation since bacteria-induced FOXO1 nuclear localiza-
tion in neutrophils was reduced by inhibition of ROS/NOS and 
deacetylation inhibitors including an inhibitor of SIRT1. This is 
consistent with findings that FOXO1 nuclear localization is stim-
ulated by induction of ROS/NOS (48) and TLR stimulates ROS 
and NOS production (49, 50). Similarly FOXO1 activation has 
been shown to be dependent upon its deacetylation (51). These 
results indicate that FOXO1 may sensitize neutrophils to bacte-
rial stimulation through upregulation of TLR2/4 and enhance 
neutrophil-mediated inflammation by increasing inflammatory 
cytokine expression. The ability of FOXO1 to enhance inflamma-
tion in neutrophils is dependent upon generation of ROS/NOS 
and the deacetylation of FOX1. Furthermore, FOXO1 appears to 
positively interact with TLR signaling pathways as the upregula-
tion of TNFα and IL-1β was much greater when neutrophils were 
transfected with a vector expressing FOXO1 and stimulated with 
bacteria compared to bacterial stimulation or FOXO1 transfec-
tion alone.
In summary, we describe a novel function for FOXO1 in 
regulating neutrophil activity in  vivo, particularly chemotaxis, 
stimulation of bacterial phagocytosis, and bacterial clearance. 
Moreover, bacteria-induced activation of FOXO1 was dependent 
upon TLR2 and/or TLR4 and FOXO1 overexpression signifi-
cantly enhanced cytokine expression induced by bacterial stimu-
lation. FOXO1 regulated several downstream genes that affect 
neutrophil function including CXCR2 and CD11b which play an 
important role in neutrophil response to bacterial challenge. Thus 
FOXO1 coordinates upregulation of neutrophil activity through 
key downstream target genes to modulate neutrophil function.
eThics sTaTeMenT
This study was carried out in accordance with the recom-
mendations of the guidelines of the University of Pennsylvania 
Institutional Animal Care and Use Committee. The protocol was 
13
Dong et al. FOXO1 Regulates Neutrophil Activity
Frontiers in Immunology | www.frontiersin.org September 2017 | Volume 8 | Article 1088
approved by University of Pennsylvania Institutional Animal 
Care and Use Committee.
aUThOr cOnTriBUTiOns
GD and DG conceived and designed the research. GD, LS, CT, 
YW, FM, JZ, CL, and SA performed experiments. GD and DG 
analyzed the data. GD and DG interpreted the results. GD and 
DG prepared figures and drafted the manuscript. GD, LS, and 
DG edited and revised the manuscript. All authors approved the 
final manuscript version.
acKnOWleDgMenTs
We would like to thank Omar Alhamwee and Vipulkumar 
Maheshwari for assistance with genotyping. We would like 
to thank Dr. Ronald DePinho for generously providing the 
FOXO1L/L mice.
FUnDing
This work was supported by National Institutes of Health funding 
from the DE-019108 and DE-021921.
reFerences
1. Bostanci N, Thurnheer T, Aduse-Opoku J, Curtis MA, Zinkernagel AS, 
Belibasakis GN. Porphyromonas gingivalis regulates TREM-1 in human poly-
morphonuclear neutrophils via its gingipains. PLoS One (2013) 8(10):e75784. 
doi:10.1371/journal.pone.0075784 
2. Moutsopoulos NM, Konkel J, Sarmadi M, Eskan MA, Wild T, Dutzan N, 
et al. Defective neutrophil recruitment in leukocyte adhesion deficiency type 
I disease causes local IL-17-driven inflammatory bone loss. Sci Transl Med 
(2014) 6(229):229ra40. doi:10.1126/scitranslmed.3007696 
3. De Filippo K, Dudeck A, Hasenberg M, Nye E, van Rooijen N, Hartmann K, 
et al. Mast cell and macrophage chemokines CXCL1/CXCL2 control the early 
stage of neutrophil recruitment during tissue inflammation. Blood (2013) 
121(24):4930–7. doi:10.1182/blood-2013-02-486217 
4. Hol J, Wilhelmsen L, Haraldsen G. The murine IL-8 homologues KC, MIP-2, 
and LIX are found in endothelial cytoplasmic granules but not in Weibel-
Palade bodies. J Leukoc Biol (2010) 87(3):501–8. doi:10.1189/jlb.0809532 
5. Eash KJ, Greenbaum AM, Gopalan PK, Link DC. CXCR2 and CXCR4 antag-
onistically regulate neutrophil trafficking from murine bone marrow. J Clin 
Invest (2010) 120(7):2423–31. doi:10.1172/JCI41649 
6. Huppler AR, Conti HR, Hernandez-Santos N, Darville T, Biswas PS, Gaffen SL. 
Role of neutrophils in IL-17-dependent immunity to mucosal candidiasis. 
J Immunol (2014) 192(4):1745–52. doi:10.4049/jimmunol.1302265 
7. Hajishengallis G, Liang S, Payne MA, Hashim A, Jotwani R, Eskan MA, et al. 
Low-abundance biofilm species orchestrates inflammatory periodontal dis-
ease through the commensal microbiota and complement. Cell Host Microbe 
(2011) 10(5):497–506. doi:10.1016/j.chom.2011.10.006 
8. Chintakuntlawar AV, Chodosh J. Chemokine CXCL1/KC and its receptor 
CXCR2 are responsible for neutrophil chemotaxis in adenoviral keratitis. 
J Interferon Cytokine Res (2009) 29(10):657–66. doi:10.1089/jir.2009.0006 
9. Sahingur SE, Yeudall WA. Chemokine function in periodontal disease and oral 
cavity cancer. Front Immunol (2015) 6:214. doi:10.3389/fimmu.2015.00214 
10. Lee WL, Harrison RE, Grinstein S. Phagocytosis by neutrophils. Microbes 
Infect (2003) 5(14):1299–306. doi:10.1016/j.micinf.2003.09.014 
11. Galicia JC, Benakanakere MR, Stathopoulou PG, Kinane DF. Neutrophils 
rescue gingival epithelial cells from bacterial-induced apoptosis. J Leukoc Biol 
(2009) 86(1):181–6. doi:10.1189/jlb.0109003 
12. Nilsson M, Weineisen M, Andersson T, Truedsson L, Sjobring U. Critical 
role for complement receptor 3 (CD11b/CD18), but not for Fc receptors, in 
killing of Streptococcus pyogenes by neutrophils in human immune serum. Eur 
J Immunol (2005) 35(5):1472–81. doi:10.1002/eji.200424850 
13. Luo HR, Loison F. Constitutive neutrophil apoptosis: mechanisms and regula-
tion. Am J Hematol (2008) 83(4):288–95. doi:10.1002/ajh.21078 
14. Hajishengallis G. Periodontitis: from microbial immune subversion to 
systemic inflammation. Nat Rev Immunol (2015) 15(1):30–44. doi:10.1038/ 
nri3785 
15. Sabroe I, Dower SK, Whyte MK. The role of toll-like receptors in the regulation 
of neutrophil migration, activation, and apoptosis. Clin Infect Dis (2005) 
41(Suppl 7):S421–6. doi:10.1086/431992 
16. Dong G, Wang Y, Xiao W, Pacios Pujado S, Xu F, Tian C, et al. FOXO1 reg-
ulates dendritic cell activity through ICAM-1 and CCR7. J Immunol (2015) 
194(8):3745–55. doi:10.4049/jimmunol.1401754 
17. Brown J, Wang H, Suttles J, Graves DT, Martin M. mTORC2 negatively 
regulates the toll-like receptor 4-mediated inflammatory response via FoxO1. 
J Biol Chem (2011) 286(52):44295–305. doi:10.1074/jbc.M111.258053 
18. Ouyang W, Liao W, Luo CT, Yin N, Huse M, Kim MV, et al. Novel Foxo1-
dependent transcriptional programs control T(reg) cell function. Nature 
(2012) 491(7425):554–9. doi:10.1038/nature11581 
19. Kim MV, Ouyang W, Liao W, Zhang MQ, Li MO. The transcription factor 
Foxo1 controls central-memory CD8+ T cell responses to infection. Immunity 
(2013) 39(2):286–97. doi:10.1016/j.immuni.2013.07.013 
20. Wang Y, Dong G, Jeon HH, Elazizi M, La LB, Hameedaldeen A, et al. FOXO1 
mediates RANKL-induced osteoclast formation and activity. J Immunol 
(2015) 194(6):2878–87. doi:10.4049/jimmunol.1402211 
21. Paik JH, Kollipara R, Chu G, Ji H, Xiao Y, Ding Z, et al. FoxOs are lineage- 
restricted redundant tumor suppressors and regulate endothelial cell homeostasis. 
Cell (2007) 128(2):309–23. doi:10.1016/j.cell.2006.12.029 
22. Maresz KJ, Hellvard A, Sroka A, Adamowicz K, Bielecka E, Koziel J, et  al. 
Porphyromonas gingivalis facilitates the development and progression of 
destructive arthritis through its unique bacterial peptidylarginine deiminase 
(PAD). PLoS Pathog (2013) 9(9):e1003627. doi:10.1371/journal.ppat.1003627 
23. Zhou Q, Desta T, Fenton M, Graves DT, Amar S. Cytokine profiling of 
macrophages exposed to Porphyromonas gingivalis, its lipopolysaccharide, 
or its FimA protein. Infect Immun (2005) 73(2):935–43. doi:10.1128/
IAI.73.2.935-943.2005 
24. Graves DT, Naguib G, Lu H, Desta T, Amar S. Porphyromonas gingivalis 
fimbriae are pro-inflammatory but do not play a prominent role in the 
innate immune response to P. gingivalis. J Endotoxin Res (2005) 11(1):13–8. 
doi:10.1179/096805105225006722 
25. Liu R, Desta T, Raptis M, Darveau RP, Graves DT. P. gingivalis and E. coli 
lipopolysaccharides exhibit different systemic but similar local induction 
of inflammatory markers. J Periodontol (2008) 79(7):1241–7. doi:10.1902/
jop.2008.070575 
26. Gonzalez D, Tzianabos AO, Genco CA, Gibson  FC III. Immunization with 
Porphyromonas gingivalis capsular polysaccharide prevents P. gingivalis-elic-
ited oral bone loss in a murine model. Infect Immun (2003) 71(4):2283–7. 
doi:10.1128/IAI.71.4.2283-2287.2003 
27. Maekawa T, Krauss JL, Abe T, Jotwani R, Triantafilou M, Triantafilou K, et al. 
Porphyromonas gingivalis manipulates complement and TLR signaling to 
uncouple bacterial clearance from inflammation and promote dysbiosis. Cell 
Host Microbe (2014) 15(6):768–78. doi:10.1016/j.chom.2014.05.012 
28. Semerad CL, Liu F, Gregory AD, Stumpf K, Link DC. G-CSF is an essential 
regulator of neutrophil trafficking from the bone marrow to the blood. 
Immunity (2002) 17(4):413–23. doi:10.1016/S1074-7613(02)00424-7 
29. Servant G, Weiner OD, Herzmark P, Balla T, Sedat JW, Bourne HR. Polarization 
of chemoattractant receptor signaling during neutrophil chemotaxis. Science 
(2000) 287(5455):1037–40. doi:10.1126/science.287.5455.1037 
30. Herrera BS, Hasturk H, Kantarci A, Freire MO, Nguyen O, Kansal S, et  al. 
Impact of resolvin E1 on murine neutrophil phagocytosis in type 2 diabetes. 
Infect Immun (2015) 83(2):792–801. doi:10.1128/IAI.02444-14 
31. Belstrom D, Holmstrup P, Damgaard C, Borch TS, Skjodt MO, Bendtzen K, 
et al. The atherogenic bacterium Porphyromonas gingivalis evades circulating 
phagocytes by adhering to erythrocytes. Infect Immun (2011) 79(4):1559–65. 
doi:10.1128/IAI.01036-10 
14
Dong et al. FOXO1 Regulates Neutrophil Activity
Frontiers in Immunology | www.frontiersin.org September 2017 | Volume 8 | Article 1088
32. Jin X, Wang L, Wu HS, Zhang L, Wang CY, Tian Y, et  al. N-acetylcysteine 
inhibits activation of toll-like receptor 2 and 4 gene expression in the liver and 
lung after partial hepatic ischemia-reperfusion injury in mice. Hepatobiliary 
Pancreat Dis Int (2007) 6(3):284–9. 
33. Bailey KL, Sisson JH, Romberger DJ, Robinson JE, Wyatt TA. Alcohol up- 
regulates TLR2 through a NO/cGMP dependent pathway. Alcohol Clin Exp 
Res (2010) 34(1):51–6. doi:10.1111/j.1530-0277.2009.01065.x 
34. Siqueira MF, Flowers S, Bhattacharya R, Faibish D, Behl Y, Kotton DN, et al. 
FOXO1 modulates osteoblast differentiation. Bone (2011) 48(5):1043–51. 
doi:10.1016/j.bone.2011.01.019 
35. Abram CL, Roberge GL, Hu Y, Lowell CA. Comparative analysis of the 
efficiency and specificity of myeloid-Cre deleting strains using ROSA-
EYFP reporter mice. J Immunol Methods (2014) 408:89–100. doi:10.1016/j.
jim.2014.05.009 
36. Segal AW. How neutrophils kill microbes. Annu Rev Immunol (2005) 
23:197–223. doi:10.1146/annurev.immunol.23.021704.115653 
37. van Spriel AB, Leusen JH, van Egmond M, Dijkman HB, Assmann KJ, 
Mayadas TN, et  al. Mac-1 (CD11b/CD18) is essential for Fc receptor-me-
diated neutrophil cytotoxicity and immunologic synapse formation. Blood 
(2001) 97(8):2478–86. doi:10.1182/blood.V97.8.2478 
38. Behl Y, Siqueira M, Ortiz J, Li J, Desta T, Faibish D, et al. Activation of the 
acquired immune response reduces coupled bone formation in response to 
a periodontal pathogen. J Immunol (2008) 181(12):8711–8. doi:10.4049/
jimmunol.181.12.8711 
39. Xiao W, Dong G, Pacios S, Alnammary M, Barger LA, Wang Y, et  al. 
FOXO1 deletion reduces dendritic cell function and enhances suscepti-
bility to periodontitis. Am J Pathol (2015) 185(4):1085–93. doi:10.1016/j.
ajpath.2014.12.006 
40. Wang Y, Zhou Y, Graves DT. FOXO transcription factors: their clin-
ical significance and regulation. Biomed Res Int (2014) 2014:925350. 
doi:10.1155/2014/925350 
41. Peng SL. Foxo in the immune system. Oncogene (2008) 27(16):2337–44. 
doi:10.1038/onc.2008.26 
42. Gubbels Bupp MR, Edwards B, Guo C, Wei D, Chen G, Wong B, et al. T cells 
require Foxo1 to populate the peripheral lymphoid organs. Eur J Immunol 
(2009) 39(11):2991–9. doi:10.1002/eji.200939427 
43. Sander S, Chu VT, Yasuda T, Franklin A, Graf R, Calado DP, et al. PI3 kinase 
and FOXO1 transcription factor activity differentially control B  cells in 
the germinal center light and dark zones. Immunity (2015) 43(6):1075–86. 
doi:10.1016/j.immuni.2015.10.021 
44. Furze RC, Rankin SM. Neutrophil mobilization and clearance in the bone 
marrow. Immunology (2008) 125(3):281–8. doi:10.1111/j.1365-2567.2008. 
02950.x 
45. Herbold W, Maus R, Hahn I, Ding N, Srivastava M, Christman JW, et  al. 
Importance of CXC chemokine receptor 2 in alveolar neutrophil and exudate 
macrophage recruitment in response to pneumococcal lung infection. Infect 
Immun (2010) 78(6):2620–30. doi:10.1128/IAI.01169-09 
46. Weineisen M, Sjobring U, Fallman M, Andersson T. Streptococcal M5 protein 
prevents neutrophil phagocytosis by interfering with CD11b/CD18 recep-
tor-mediated association and signaling. J Immunol (2004) 172(6):3798–807. 
doi:10.4049/jimmunol.172.6.3798 
47. Mobberley-Schuman PS, Weiss AA. Influence of CR3 (CD11b/CD18) expres-
sion on phagocytosis of Bordetella pertussis by human neutrophils. Infect 
Immun (2005) 73(11):7317–23. doi:10.1128/IAI.73.11.7317-7323.2005 
48. Ponugoti B, Dong G, Graves DT. Role of forkhead transcription factors in 
diabetes-induced oxidative stress. Exp Diabetes Res (2012) 2012:939751. 
doi:10.1155/2012/939751 
49. West AP, Brodsky IE, Rahner C, Woo DK, Erdjument-Bromage H, Tempst P, 
et al. TLR signalling augments macrophage bactericidal activity through mito-
chondrial ROS. Nature (2011) 472(7344):476–80. doi:10.1038/nature09973 
50. Zhan R, Han Q, Zhang C, Tian Z, Zhang J. Toll-like receptor 2 (TLR2) 
and TLR9 play opposing roles in host innate immunity against Salmonella 
enterica serovar typhimurium infection. Infect Immun (2015) 83(4):1641–9. 
doi:10.1128/IAI.02870-14 
51. Hameedaldeen A, Liu J, Batres A, Graves GS, Graves DT. FOXO1, TGF-
beta regulation and wound healing. Int J Mol Sci (2014) 15(9):16257–69. 
doi:10.3390/ijms150916257 
Conflict of Interest Statement: The authors declare that the research was 
conducted in the absence of any commercial or financial relationships that could 
be construed as a potential conflict of interest.
Copyright © 2017 Dong, Song, Tian, Wang, Miao, Zheng, Lu, Alsadun and Graves. 
This is an open-access article distributed under the terms of the Creative Commons 
Attribution License (CC BY). The use, distribution or reproduction in other forums 
is permitted, provided the original author(s) or licensor are credited and that the 
original publication in this journal is cited, in accordance with accepted academic 
practice. No use, distribution or reproduction is permitted which does not comply 
with these terms.
